A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
Status:
Terminated
Trial end date:
2010-10-28
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the safety and efficacy of the infusion of
partially matched, allogeneic, CMV specific cytotoxic T cells (CTL) for patients with GBM
that have failed primary therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Milton S. Hershey Medical Center Penn State University